arrow-left-endarrow-right-end

News & Updates

The Latest on Internet Pharmacies, Supplements, Designer Drugs,
and Other High-Risk Merchants

Filter By:

The Top Marketing Claims CBD Merchants and Manufacturers Should Avoid

One of the aspects of cannabidiol (CBD) sales that can attract regulatory scrutiny is the way in which merchants market their CBD products. In the past five years, the FDA has sent many warning letters to manufacturers and merchants of CBD products for claims that their products can prevent, cure, mitigate, or treat diseases. No…

Continue Reading ›

LegitScript Announces New CBD Certification Program

We’re happy to announce a new certification program for legally compliant CBD products and websites. Starting today, US manufacturers and merchants can apply through LegitScript to certify CBD products and websites that are in compliance with USDA, FDA, FTC, and DEA regulations, as well as state-specific laws. LegitScript is the global leader in merchant and…

Continue Reading ›

What the Blackstone Labs Indictment Means for Payment Service Providers

Last month, six people associated with Blackstone Labs were charged in an indictment to market and sell illegal dietary supplements for use in bodybuilding and weight loss. The indictment is significant because of the size and reach of Blackstone Labs, and because of the way it is alleged to have deceptively labeled products for years.…

Continue Reading ›

Three Things Payment Service Providers Need to Know About CBD Sales

The 2018 Farm Bill, which was signed into law last month, includes provisions removing hemp and its extracts, including hemp-derived cannabidiol (CBD), from the DEA’s Controlled Substances schedules entirely. This is a monumental shift for industrial hemp and CBD in the US, and it promises big opportunities for CBD merchants and the payment facilitators that…

Continue Reading ›

How Will the FDA’s New Dietary Supplement Working Group Affect You?

Food and Drug Administration Commissioner Scott Gottlieb announced last month a new working group to improve oversight of the dietary supplement industry. The move could mean increased safety for consumers, but also increased scrutiny of dietary supplement merchants and the payment facilitators that onboard them. An Unwieldy Industry In a speech at the Food and…

Continue Reading ›

The Problem With Glucosamine Supplements

As a public service, LegitScript offers free limited product lookups so that people can check to see if a product they have purchased is dangerous or otherwise problematic. Frequently, we get searches for products that contain problematic ingredients such as marijuana, kratom, and SARMs. But we’ve noticed that one of the top ingredient searches on…

Continue Reading ›

When is a Legal Dietary Supplement Illegal?

Most countries have regulatory authorities like the Food and Drug Administration that monitor and establish rules around food, drugs, dietary supplements, and more. These agencies have their own complex laws and regulatory standards, and they often vary substantially. What may be a legal, unregulated ingredient in one country is a prescription drug in another, and…

Continue Reading ›

E-cigarettes Remain a Pervasive Problem for Youth

Tobacco use among youth in the US is down, but e-cigarettes still pose the greatest challenge to reducing nicotine consumption among middle and high schoolers. These are the findings of the 2017 National Youth Tobacco Survey, released this month by The Centers for Disease Control and Prevention (CDC) and the US Food and Drug Administration…

Continue Reading ›

Kratom: Addiction Treatment or Addictive Opioid?

As mentioned in our last post, LegitScript has noticed a trend to market kratom as an opioid alternative and an opiate withdrawal aid. Today, we’re taking a closer look at this plant, which has been the subject of some recent alarming warnings by the FDA. Kratom, also known as Mitragyna speciosa, is a tree that grows naturally in Thailand,…

Continue Reading ›

FDA Attempts to Define Rules for Burgeoning Stem Cell Clinic Industry

Recent news is replete with stories about the potential of stem cell therapy as well as cautionary tales about unscrupulous stem cell clinics that promise cures for chronic diseases but fail to deliver. Confusion over stem cell therapy is widespread enough that, in late 2017, the FDA Commissioner issued a statement promising a comprehensive policy…

Continue Reading ›